UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934. For the fiscal year ended April 28, 2023. ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from __________ to __________ Commission File No. 1-36820 ® Medtronic plc (Exact name of registrant as specified in its charter) Ireland 98-1183488 (State or other jurisdiction of in ...

Medtronic plc (NYSE:MDT) Goldman Sachs 44th Annual Global Healthcare Conference Call June 12, 2023 1:40 PM ET Company Participants Geoff Martha - Chairman and Chief Executive Officer Conference Call Participants Jamie Perse - Goldman Sachs Jamie Perse All right. Good morning, everyone. I'm Jamie Perse, healthcare provider analyst at Goldman Sachs, and I've formally been on the medtech team as well. Our next panel is with Medtronic. We've got the Chairman and CEO, Geoff Martha. Thank you for joining. Geoff M ...

Medtronic plc (NYSE:MDT) Q4 2023 Earnings Conference Call May 25, 2023 8:00 AM ET Company Participants Ryan Weispfenning - VP, IR Geoffrey Martha - Chairman & CEO Karen Parkhill - CFO Brad Welnick - IR Que Dallara - EVP & President, Diabetes Operating Unit Sean Salmon - EVP & President, Cardiovascular Portfolio Brett Wall - EVP & President, Neuroscience Portfolio Bob White - EVP & President, Medical Surgical Portfolio Conference Call Participants Robert Marcus - JPMorgan Vijay Kumar - Evercore ISI Larry Bie ...

th 44 Annual Raymond James Institutional Investors Conference Orlando • March 2023 ...

Medtronic plc (NYSE:MDT) Cowen 43rd Annual Healthcare Conference March 6, 2023 10:30 AM ET Company Participants Karen Parkhill - Executive Vice President and Chief Financial Officer Conference Call Participants Josh Jennings - Cowen and Company Josh Jennings We are moving down the medical devices track here at the TD Cowen 43rd Annual Healthcare Conference. We're excited to have Karen Parkhill, the Chief Financial Officer, Executive Vice President at Medtronic, the largest medical device company in the worl ...

rd 43 Annual TD Cowen Healthcare Conference Boston • March 2023 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 27, 2023 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from __________ to __________ Commission File Number 001-36820 ® Medtronic plc (Exact name of registrant as specified in its charter) Ireland 98-1183488 (State of incorporation) (I.R ...

Not started Work in progress Update complete Medtronic plc Q3 FY23 Earnings presentation ...

Medtronic plc (NYSE:MDT) Q3 2023 Earnings Conference Call February 21, 2023 8:00 AM ET Company Participants Ryan Weispfenning - Investor Relations Geoff Martha - Chairman and Chief Executive Officer Karen Parkhill - Chief Financial Officer Bob White - Executive Vice President and President, Medical Surgical Portfolio Brett Wall - Executive Vice President and President, Neuroscience Portfolio Que Dallara - Executive Vice President and President, Diabetes Operating Unit Sean Salmon - Executive Vice President ...

41st annual J.P. Morgan healthcare conference Geoff Martha, Chairman and CEO January 9, 2023 San Francisco Forward-looking statements, non-GAAP financial measures, and comparisons Forward-looking statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties, including risks related to competitive factors, difficulties and delays inherent in the development, manufacturing, marketing and ...